Cogent Biosciences Inc (NASDAQ:COGT)
| 9.45 Delayed Data As of Jul 01 |  +0.43 / +4.77%Today’s Change | 3.79 Today|||52-Week Range 11.06 | +10.14% Year-to-Date |
Latest COGT News | Press Releases
No recent news for Cogent Biosciences Inc.
Today’s Trading
| Previous close | 9.02 |
| Today’s open | 8.83 |
| Day’s range | 8.83 - 9.45 |
| Volume | 27,375 |
| Average volume (3 months) | 2,054,746 |
| Market cap | $830.2M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +88.46% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRNESorrento Therapeutic... | +0.14 | +6.97% |
| MORFMorphic Holding Inc | +0.49 | +2.26% |
| ---- | ||
| EDITEditas Medicine Inc | +0.77 | +6.51% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$72.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
